Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Zyla Life Sciences (ZCOR) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $2.00 Metrics
OS: 9.61 M
Market cap: $19.2 M
Net cash: $14.5 M $1.51 per share
EV: $4.68 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11
Revenues30.426.117.022.81.90.01.25.1
            Revenue growth16.1%54.1%-25.7%1089.1% -100.0%-76.4% 
Cost of goods sold7.45.23.73.30.00.00.04.5
Gross profit22.921.013.319.61.90.01.20.6
            Gross margin75.5%80.3%78.4%85.7%100.0% 100.0%12.3%
Sales and marketing33.735.527.916.30.9   
Research and development3.514.733.827.122.46.34.3 
General and administrative24.134.130.726.515.75.12.22.1
EBIT-36.2-65.4-81.0-52.2-37.1-11.4-5.3-5.9
            EBIT margin-119.3%-250.4%-477.6%-228.7%-1934.2% -441.0%-116.0%
Pre-tax income-95.5-69.4-91.7-58.7-43.2-20.2-5.4-6.5
Income taxes0.00.0-1.1-0.70.00.00.00.0
            Tax rate0.0%0.0%1.2%1.2%  0.0%0.0%
Net income-95.5-69.4-90.6-57.9-43.2-20.2-5.4-6.5
            Net margin-314.5%-265.4%-534.3%-253.8%-2250.7% -449.5%-126.8%
 
Diluted EPS($1.81)($2.05)($3.70)($2.94)($2.97)($15.64)($4.18)($5.00)
Shares outstanding (diluted)52.833.824.519.714.61.31.31.3
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy